A woman who had a large ovarian cyst removed last year subsequently developed pelvic inflammatory disease (PID) with Acinetobacter baumannii infection that was refractory to doxycycline plus metronidazole, fluconazole, meropenem, and levofloxacin, and is now improving on amoxicillin‑clavulanate (875 mg/125 mg) plus metronidazole; what is the appropriate management and follow‑up advice?

Management of Refractory PID with Acinetobacter baumannii

Continue the amoxicillin-clavulanate plus metronidazole for a total of 14 days, then reassess with repeat culture and clinical examination to confirm eradication.

Clinical Reasoning

This patient presents with a complex, treatment-refractory PID case that has finally responded to amoxicillin-clavulanate plus metronidazole after multiple failed regimens. The key issue here is that Acinetobacter baumannii is not a typical PID pathogen and suggests either healthcare-associated infection (given her prior surgery) or polymicrobial infection where typical PID organisms may have been inadequately treated.

Why the Current Regimen is Working

The improvement with amoxicillin-clavulanate plus metronidazole after 5 days suggests:

• Amoxicillin-clavulanate provides coverage for many Acinetobacter species outside the A. baumannii-calcoaceticus complex, which typically show >90% susceptibility to beta-lactam/beta-lactamase inhibitor combinations 1
• Metronidazole addresses anaerobic co-pathogens that are common in PID and were likely inadequately treated by prior regimens 2
• The polymicrobial nature of PID requires broad-spectrum coverage including anaerobes, gram-negative rods, and streptococci 2

Treatment Duration and Completion

Complete a full 14-day course of the current regimen 2. The PID guidelines emphasize that:

• Standard PID treatment requires 10-14 days of therapy 2
• Stopping antibiotics prematurely increases treatment failure risk and promotes resistance development 3
• The patient has only completed 5 days—insufficient for complete eradication

Post-Treatment Follow-Up (Critical)

At 72 hours after completing antibiotics:

• Repeat high vaginal swab culture specifically for Acinetobacter baumannii
• Clinical examination for cervical motion tenderness, adnexal tenderness, or discharge
• If discharge persists or culture remains positive, obtain antimicrobial susceptibility testing

At 2-4 weeks post-treatment:

• Repeat pelvic examination
• Screen for Chlamydia trachomatis and Neisseria gonorrhoeae (often missed in chronic cases)
• Assess for complications: tubo-ovarian abscess, chronic pelvic pain, or hydrosalpinx

Why Prior Treatments Failed

The treatment cascade reveals important lessons:

1. Doxycycline + metronidazole failure: Standard PID regimen but lacks activity against many gram-negative rods including Acinetobacter 4
2. Fluconazole: Antifungal—completely inappropriate for bacterial PID
3. Meropenem failure: Surprising given it's a carbapenem, but suggests either:
   • Carbapenem-resistant Acinetobacter baumannii (CRAB) 5
   • Inadequate anaerobic coverage (meropenem alone doesn't cover all anaerobes optimally)
   • Non-baumannii Acinetobacter species with different susceptibility patterns
4. Levofloxacin failure: Quinolone resistance is common in Acinetobacter 1

Critical Pitfalls to Avoid

Do not stop antibiotics at day 5-7 despite symptom improvement 3. This is the most common error and leads to:

• Incomplete bacterial eradication
• Recurrent infection
• Development of antibiotic resistance
• Long-term sequelae (infertility, chronic pelvic pain, ectopic pregnancy risk) 2

Do not assume this is simple PID. The presence of Acinetobacter baumannii suggests:

• Possible healthcare-associated infection from her prior ovarian cyst surgery
• Need for imaging to exclude tubo-ovarian abscess or retained foreign material
• Consider pelvic ultrasound if not recently performed

Ensure partner treatment. Even with atypical organisms, evaluate and treat sexual partners empirically for Chlamydia and gonorrhea 2

If Treatment Fails Again

Should symptoms recur or cultures remain positive after completing 14 days:

1. Obtain antimicrobial susceptibility testing for the Acinetobacter isolate
2. Consider hospitalization for parenteral therapy 2. This patient meets criteria: failed outpatient therapy multiple times
3. Imaging: Transvaginal ultrasound or CT to exclude abscess formation
4. Consult infectious disease for multidrug-resistant Acinetobacter management, which may require sulbactam-based regimens or cefiderocol 6, 5
5. Gynecology consultation to exclude structural complications requiring surgical intervention

Monitoring During Current Treatment

• Counsel the patient to complete all 14 days even though she feels better 3
• Watch for severe diarrhea (Clostridioides difficile risk with prolonged antibiotics) 3
• Take with food to reduce gastrointestinal upset 3
• Return immediately if fever, worsening pain, or new symptoms develop

The key to success here is completing the full antibiotic course and confirming microbiological cure, not just symptomatic improvement. The multiple treatment failures indicate this is a complicated case requiring meticulous follow-up to prevent long-term reproductive complications.